Role of Tranexamic Acid Reduces Perioperative Blood Loss in Spine Surgery

Prophylactic Dose of Tranexamic Acid Reduces Perioperative Blood Loss in Spine Surgery: A comparison between two different doses.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201611001846189

Enrollment

Registered

2016-11-02

Start date

2014-04-02

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery postoperative blood loss

Interventions

Group C

Group HD

Group LD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ages ranged between 28: 65 years ASA I and II BMI < 35 kg/m2 Posterior arthrodesis with fusion of one or two levels

Exclusion criteria

Exclusion criteria: uncontrolled hypertension liver or renal impairment congenital or syndromic scoliosis fixation of more than 2 levels Previous spinal surgery coagulopathies patients who received anticoagulant or any drug that may interfere with the study drugs

Design outcomes

Primary

Measure	Time frame
The total amount of blood loss	—

Secondary

Measure	Time frame
Hemoglobin concentration	—

Countries

Egypt

Contacts

Public ContactAhmed Abd El-Hamid

assistant professor

bashaahmad@yahoo.com+201005204130

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026